These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1440342)

  • 1. [The role of disorders in the structural-functional properties of the erythrocyte membranes and energy metabolism in the progression of anemia in patients with terminal kidney failure].
    Iudanova LS; Iakovleva EV; Zakharova NB; Cherneva II
    Ter Arkh; 1992; 64(6):63-6. PubMed ID: 1440342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure].
    Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa
    Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phospholipid composition of erythrocytes in patients with chronic kidney failure].
    Akalaev RN; Abidov AA
    Vopr Med Khim; 1993; 39(5):43-5. PubMed ID: 8279143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
    Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
    Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid peroxidation as a possible mechanism of erythrocyte damage in patients with chronic kidney failure on hemodialysis].
    Balashova TS; Rud'ko IA; Ermolenko VM; Tsalenchuk IaP; Kubatiev AA
    Ter Arkh; 1992; 64(6):66-9. PubMed ID: 1440343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure.
    Loschiavo C; Ferrari S; Aprili F; Grigolini L; Faccini G; Maschio G
    Clin Nephrol; 1990 Dec; 34(6):267-71. PubMed ID: 2073770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte lipids in chronic renal failure.
    Pielichowski J; Kwiatkowska J; Zatoński W
    Arch Immunol Ther Exp (Warsz); 1977; 25(2):213-7. PubMed ID: 869679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phospholipid composition and content of the erythrocyte membrane in carriers of sickle cell trait].
    Sarr NG; Sall ND; Toure M; Diatta A; Seck I
    Dakar Med; 1998; 43(1):5-8. PubMed ID: 9827146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in red blood cell membrane structure in patients with chronic renal failure.
    Gwoździński K; Janicka M; Brzeszczyńska J; Luciak M
    Acta Biochim Pol; 1997; 44(1):99-107. PubMed ID: 9241360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical and functional characteristics of erythrocyte membranes in sportsmens with anemia].
    Hunina LM; Oliĭnyk SA; Ivanov SV
    Fiziol Zh (1994); 2007; 53(3):43-50. PubMed ID: 17725043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The morphofunctional damage to the biomembranes in the lipid peroxidation syndrome in patients with the terminal stage of chronic kidney failure].
    Grinshteĭn IuI; Linev KA
    Urol Nefrol (Mosk); 1989; (6):45-8. PubMed ID: 2617738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
    Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane lipid components associated with increased filterability of erythrocytes from long-distance runners.
    Nakano T; Wada Y; Matsumura S
    Clin Hemorheol Microcirc; 2001; 24(2):85-92. PubMed ID: 11381183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro.
    Pöschl JM; Leray C; Ruef P; Cazenave JP; Linderkamp O
    Crit Care Med; 2003 Mar; 31(3):924-8. PubMed ID: 12627006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C.
    Tanaka H; Miyano M; Ueda H; Fukui K; Ichinose M
    Clin Exp Med; 2005 Dec; 5(4):190-5. PubMed ID: 16362799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemodialysis on the content of fatty acids in monolayers of erythrocyte membranes in patients with chronic renal failure.
    Dolegowska B; Kwiatkowska E; Wesolowska T; Bober J; Chlubek D; Ciechanowski K
    Ren Fail; 2007; 29(4):447-52. PubMed ID: 17497467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structural changes in erythrocyte membranes in nephropathy].
    Panasenko OM; Shalina RI; Azizova OA
    Biull Eksp Biol Med; 1985 Apr; 99(4):434-7. PubMed ID: 2985155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The erythrocyte functional status and phospholipid composition in breast cancer patients].
    Domanskiĭ VIu
    Vopr Onkol; 1992; 38(10):1194-202. PubMed ID: 1343145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the lipid content of erythrocytes in patients with chronic renal failure].
    Witkowska J; Bober J; Chlubek D
    Ann Acad Med Stetin; 2007; 53(2):46-51. PubMed ID: 18557376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.